A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer

Publication Title

SITC 2021

Document Type

Article

Publication Date

2021

Keywords

oregon; washington; chiles

Area of Special Interest

Cancer

Area of Special Interest

Women & Children

Specialty/Research Institute

Earle A. Chiles Research Institute

Specialty/Research Institute

Oncology

This document is currently not available here.


Share

COinS